Status:
COMPLETED
A Safety Study of ARRY-371797 in Healthy Subjects
Lead Sponsor:
Array Biopharma, now a wholly owned subsidiary of Pfizer
Conditions:
Healthy
Eligibility:
All Genders
18-60 years
Phase:
PHASE1
Brief Summary
This is a Phase 1 study, involving both 1-day and 8-day dosing periods, designed to test the safety of investigational study drug ARRY-371797 in healthy subjects. Approximately 48 healthy subjects fro...
Eligibility Criteria
Inclusion
- Key
- Healthy male or female between the ages of 18 and 60 years.
- Females must be of nonchildbearing potential.
- Body weight \> 50 kg (110 lbs) and \< 113 kg (250 lbs).
- Additional criteria exist.
- Key
Exclusion
- A positive test for drugs or alcohol.
- Use of prescription or nonprescription drugs, herbal or dietary supplements, vitamins, or grapefruit juice within 14 days prior to first dose of study drug.
- Additional criteria exist.
Key Trial Info
Start Date :
October 31 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 21 2009
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00790049
Start Date
October 31 2008
End Date
January 21 2009
Last Update
May 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PPD Phase I Clinic
Austin, Texas, United States, 78744